Literature DB >> 19177156

Insulin resistance and altered glucose transporter 4 expression in experimental uremia.

Dunja Aksentijević1, Sunil Bhandari, Anne-Marie L Seymour.   

Abstract

Progressive ventricular hypertrophy can lead to the development of insulin resistance, a feature of both chronic kidney disease and heart failure. Here we induced uremia in adult male Sprague-Dawley rats using a remnant kidney model and studied the expression of glucose transporters. As expected, the reduction of nephron mass resulted in impaired renal function, cardiac hypertrophy, glucose intolerance, hyperinsulinemia, anemia, and hypertension. Insulin sensitivity was significantly reduced in the uremic animals as determined by oral glucose tolerance tests. After six weeks of uremia, at a point when cardiac hypertrophy had been established, left ventricle tissue had a marked increase in the expression of GLUT4 (insulin-dependent glucose transporter 4), consistent with hypertrophic remodeling, but not GLUT1 (insulin-independent glucose transporter 1). However, although uremic animals had systemic insulin resistance and glucose intolerance, there was no evidence of impaired GLUT4 translocation in the heart at 6 weeks of uremia, suggesting that other mechanisms may underpin insulin resistance in the uremic heart.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19177156     DOI: 10.1038/ki.2008.691

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Correlates of insulin resistance in older individuals with and without kidney disease.

Authors:  Michael Landau; Manjula Kurella-Tamura; Michael G Shlipak; Alka Kanaya; Elsa Strotmeyer; Annemarie Koster; Suzanne Satterfield; Eleanor M Simsonick; Bret Goodpaster; Anne B Newman; Linda F Fried
Journal:  Nephrol Dial Transplant       Date:  2011-01-19       Impact factor: 5.992

Review 2.  Cardiac metabolic remodelling in chronic kidney disease.

Authors:  Nikayla Patel; Muhammad Magdi Yaqoob; Dunja Aksentijevic
Journal:  Nat Rev Nephrol       Date:  2022-05-30       Impact factor: 42.439

Review 3.  Relationship between chronic kidney disease and metabolic syndrome: current perspectives.

Authors:  Khaled Nashar; Brent M Egan
Journal:  Diabetes Metab Syndr Obes       Date:  2014-09-18       Impact factor: 3.168

4.  Mechanism of insulin resistance in a rat model of kidney disease and the risk of developing type 2 diabetes.

Authors:  François Dion; Christopher Dumayne; Nathalie Henley; Stéphanie Beauchemin; Edward B Arias; François A Leblond; Sylvie Lesage; Stéphane Lefrançois; Gregory D Cartee; Vincent Pichette
Journal:  PLoS One       Date:  2017-05-01       Impact factor: 3.240

Review 5.  Immunometabolic cross-talk in the inflamed heart.

Authors:  Federica M Marelli-Berg; Dunja Aksentijevic
Journal:  Cell Stress       Date:  2019-06-07

6.  A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status.

Authors:  S Bhandari; V Allgar; A Lamplugh; I Macdougall; P A Kalra
Journal:  BMC Nephrol       Date:  2021-03-30       Impact factor: 2.388

7.  Intracellular sodium elevation reprograms cardiac metabolism.

Authors:  Dunja Aksentijević; Anja Karlstaedt; Marina V Basalay; Brett A O'Brien; David Sanchez-Tatay; Seda Eminaga; Alpesh Thakker; Daniel A Tennant; William Fuller; Thomas R Eykyn; Heinrich Taegtmeyer; Michael J Shattock
Journal:  Nat Commun       Date:  2020-08-28       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.